ArticleCancers2021

Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia.

Panagiotis Tsirigotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.